Bartlett & Co Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$119K Buy
212
+1
+0.5% +$641 ﹤0.01% 536
2025
Q4
$143K Hold
211
﹤0.01% 498
2025
Q3
$135K Buy
211
+10
+5% +$6.07K ﹤0.01% 504
2025
Q2
$108K Buy
201
+1
+0.5% +$478 ﹤0.01% 530
2025
Q1
$84K Hold
200
﹤0.01% 571
2024
Q4
$82.7K Hold
200
﹤0.01% 563
2024
Q3
$101K Hold
200
﹤0.01% 544
2024
Q2
$97.4K Hold
200
﹤0.01% 547
2024
Q1
$108K Hold
200
﹤0.01% 539
2023
Q4
$111K Hold
200
﹤0.01% 555
2023
Q3
$87.5K Hold
200
﹤0.01% 564
2023
Q2
$100K Hold
200
﹤0.01% 541
2023
Q1
$100K Hold
200
﹤0.01% 466
2022
Q4
$81.6K Sell
200
-7
-3% -$2.72K ﹤0.01% 503
2022
Q3
$67.4K Sell
207
-19
-8% -$6.98K ﹤0.01% 519
2022
Q2
$79.3K Buy
226
+26
+13% +$10.6K ﹤0.01% 500
2022
Q1
$109K Buy
+200
New +$105K ﹤0.01% 477
2021
Q4
Sell
-200
Closed -$124K 624
2021
Q3
$124K Hold
200
﹤0.01% 387
2021
Q2
$126K Hold
200
﹤0.01% 383
2021
Q1
$97.9K Sell
200
-200
-50% -$100K ﹤0.01% 420
2020
Q4
$200K Hold
400
﹤0.01% 329
2020
Q3
$157K Hold
400
﹤0.01% 331
2020
Q2
$132K Sell
400
-42
-10% -$12.2K ﹤0.01% 356
2020
Q1
$107K Hold
442
﹤0.01% 361
2019
Q4
$115K Hold
442
﹤0.01% 393
2019
Q3
$120K Buy
+442
New +$123K ﹤0.01% 377

Other funds holding IDXX

Bartlett & Co Wealth Management's IDXX Position: Q1 2026 in Review

Bartlett & Co Wealth Management increased its Idexx Laboratories (IDXX) stake by 0.47% in Q1 2026, buying an estimated $641 and bringing the position to 212 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #536.

Bartlett & Co Wealth Management first reported a position in IDXX in Q3 2019 and has held it in 26 quarters since. The position peaked at $200K in Q4 2020. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Bartlett & Co Wealth Management held 212 shares of Idexx Laboratories worth $119K as of Q1 2026.
  • Bartlett & Co Wealth Management bought 1 Idexx Laboratories share in Q1 2026, an estimated $641.
  • Idexx Laboratories made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q1 2026, its #536 holding.
  • Bartlett & Co Wealth Management first reported a position in Idexx Laboratories in Q3 2019 and has held it in 26 quarters since.
  • Bartlett & Co Wealth Management's Idexx Laboratories position peaked at $200K in Q4 2020.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.